-The Hindu In addition to adequate provision of funds for cleaning, sanitation training and maintenance of toilets in schools, the issue of fixing accountability must also be addressed The revival of the issue of toilets in schools has brought to the fore a discussion that has for long existed among educationists, with varying positions occupying centre stage at different times. A couple of decades ago, when the deplorable state of education began...

-The Times of India A new self regulatory code of conduct for doctors and hospitals, in the process of being formulated, could hold investors and members on the boards of medical establishments responsible for unethical practices in the establishment such as giving cuts to doctors and diagnostic facilities or taking bribes from pharmaceutical companies. The Indian Medical Association (IMA) and the Association of Hospital Providers of India (AHPI) have constituted a joint...

-The Times of India HYDERABAD: In what could be seen a possible reflection of an agrarian crisis, 2014 farmers -- 1211 in Telangana and 803 farmers in Andhra -- committed suicide in the undivided state in 2013. The data provides a comprehensive analysis and break-up based on age, gender and districts on all farmers' suicides recorded last year. Among districts, Mahbubnagar topped the list in Telangana with 287 deaths and in Andhra, this...

-Capital Market 14 Crore Soil Health Cards to be Issued in Three Years; Credit Support of Rs. 8 Lakh Crore to Agriculture During 2014-15 Targeted "Finance to 5 lakh joint farming groups of Bhoomi Heen Kisan through NABARD in the current financial year", said Shri Radha Mohan Singh, Agriculture Minister, while inaugurating the National Rabi Conference. Minister said that, a very large number of landless farmers are unable to provide land title...

-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...